Selisistat S-enantiomer
|
(1S)-6-氯-2,3,4,9-四氢-1H-咔唑-1-甲酰胺
|
848193-68-0
|
Afuresertib hydrochloride
|
N-((S)-1-氨基-3-(3-氟苯基)丙-2-基)-5-氯-4-(4-氯-1-甲基-1H-吡唑-5-基)噻吩-2-甲酰胺盐酸盐
|
1047645-82-8
|
UNC 0631
|
UNC 0631
|
1320288-19-4
|
Tenovin-6 Hydrochloride
|
TENOVIN 2
|
1011301-29-3
|
NI-57
|
NI-57
|
1883548-89-7
|
Daphnetin
|
瑞香素
|
486-35-1
|
MS645
|
MS645
|
2250091-96-2
|
Sirtuin modulator 1
|
SIRTUIN MODULATOR 1;SRT3025 HCL
|
2070015-26-6
|
GSK046
|
VERDINEXOR
|
2474876-09-8
|
CTPB
|
CTPB
|
586976-24-1
|
ζ-Stat
|
8-羟基-1,3,6-萘三磺酸
|
3316-02-7
|
Ingenol 3,20-dibenzoate
|
巨大戟醇-3,20-二苯甲酸酯
|
59086-90-7
|
Mitoxantrone
|
米托蒽醌
|
65271-80-9
|
PKCβ inhibitor 1
|
3-[1-[3-(1H-咪唑-1-基)丙基]-1H-吲哚-3-基]-4-(苯氨基)-1H-吡咯-2,5-二酮
|
257879-35-9
|
MS436
|
(E)-4-((2-AMINO-4-HYDROXY-5-METHYLPHENYL)DIAZENYL)-N-(PYRIDIN-2-YL)BENZENESULFONAMIDE
|
1395084-25-9
|
DC_517
|
CS-2082
|
500017-70-9
|
Nicotinamide riboside chloride
|
烟酰胺核苷
|
23111-00-4
|
CMP-5
|
1-(9-ethyl-9H-carbazol-3-yl)-N-(pyridin-2-ylmethyl)methanamine
|
880813-42-3
|
Molibresib besylate
|
MOLIBRESIB BESYLATE
|
1895049-20-3
|
(-)-Indolactam V
|
吲哚内酰胺 V
|
90365-57-4
|
SRT 2183
|
SRT 2183
|
1001908-89-9
|
Afuresertib
|
GSK-2110183C
|
1047644-62-1
|
PKC-IN-1
|
[(2S,5R)-2,5-二甲基-4-[(四氢-2H-吡喃-4-基)甲基]-1-哌嗪基][3-[(5-氟-2-甲基-4-嘧啶基)氨基]-4,6-二氢-6,6-二甲基吡咯并[3,4-C]吡唑-5(1H)-基]甲酮
|
1046787-18-1
|
MI-503
|
MI-503
|
1857417-13-0
|
MI-538
|
MI-538
|
1857417-10-7
|
4'-Methoxychalcone
|
4'-甲氧基查耳酮
|
959-23-9
|
LIN28 inhibitor LI71
|
LIN28 INHIBITOR LI71
|
1357248-83-9
|
Resveratrol analog 1
|
Resveratrol analog 1
|
861446-16-4
|
UNC2399
|
|
2412791-72-9
|
AMI-1 free acid
|
猩红酸
|
134-47-4
|
Tenovin-6
|
TENOVIN-6
|
1011557-82-6
|
TPPB
|
TPPB
|
497259-23-1
|
SRT 2104
|
玻玛西林
|
1093403-33-8
|
UNC0379 TFA
|
UNC-0379 TRIFLUOROACETATE
|
1620401-83-3
|
MM-102 TFA
|
1883545-52-5
|
1883545-52-5
|
PF-CBP1 hydrochloride
|
PF-CBP1
|
2070014-93-4
|
SRT 1720 Hydrochloride
|
SRT 1720 HYDROCHLORIDE
|
2060259-60-9
|
MI-3454
|
2134169-43-8
|
2134169-43-8
|
AMI-1
|
猩红酸钠盐
|
20324-87-2
|
Mitoxantrone dihydrochloride
|
盐酸米托蒽醌
|
70476-82-3
|
SRT 1460
|
3,4,5-三甲氧基-N-(2-(3-(哌嗪-1-基甲基)咪唑并[2,1-B]噻唑-6-基)苯基)苯甲酰胺
|
925432-73-1
|
Rottlerin
|
粗糠柴苦素
|
82-08-6
|
AZ505 ditrifluoroacetate
|
N-环己基-3-[[2-(3,4-二氯苯基)乙基]氨基]-N-[2-[[2-(3,4-二氢-5-羟基-3-氧代-2H-1,4-苯并恶嗪-8-基)乙基]氨基]乙基]丙酰胺 二(2,2,2-三氟乙酸盐)
|
1035227-44-1
|
GSK2879552
|
GSK2879552
|
1401966-69-5
|
CARM1-IN-1
|
1020399-49-8
|
1020399-49-8
|
SNDX-5613
|
SNDX-5613
|
2169919-21-3
|
BMS-P5 free base
|
BMS-P5
|
1550371-22-6
|
Phorbol 12,13-dibutyrate
|
PHORBOL 12,13-DIBUTYRATE
|
37558-16-0
|
(8R,9S)-Talazoparib
|
(8R,9S)-5-氟-8-(4-氟苯基)-2,7,8,9-四氢-9-(1-甲基-1H-1,2,4-三唑-5-基)-3H-吡啶并[4,3,2-DE]酞嗪-3-酮
|
1207456-00-5
|
EPZ011989
|
化合物EPZ011989
|
1598383-40-4
|
M89
|
Anti-Vacuolar ATP synthase membrane sector-associated protein M8-9 antibody produced in rabbit
|
2363165-42-6
|
KDM5-C70
|
ethyl 2-(((2-((2-(dimethylamino)ethyl)(ethyl)amino)-2-oxoethyl)amino)methyl)isonicotinate
|
1596348-32-1
|
SIRT1-IN-1
|
化合物SIRT1-IN-1
|
352554-02-0
|
GNE-207
|
化合物 T15399
|
2158266-58-9
|
(S)-JQ-35
|
1349719-98-7
|
1349719-98-7
|
LSD1-IN-7 benzenesulfonate
|
CC-90011
|
2097523-60-7
|
OXFBD04
|
OXFBD04
|
2231747-03-6
|
T-448
|
T-448
|
1597426-53-3
|
GSK3368715 dihydrochloride
|
GSK3368715 DIHYDROCHLORIDE
|
1628925-77-8
|
Daminozide
|
丁酰肼
|
1596-84-5
|
γ-Oryzanol
|
谷维素
|
11042-64-1
|
CPI-1612
|
化合物 CPI-1612
|
2374971-81-8
|
Dehydrocorydaline
|
去氢延胡索素
|
30045-16-0
|
O6BTG-octylglucoside
|
8-[2-氨基-6-[(4-溴-2-噻吩基)甲氧基]-9H-嘌呤-9-基]辛基 BETA-D-吡喃葡萄糖苷
|
382607-78-5
|
(R)-(-)-JQ1 Enantiomer
|
(R)-(-)2-(4-(4-氯苯基)-2,3,9-三甲基-6H-噻吩并[3,2-F][1,2,4]三唑并[4,3-A][1,4]二氮杂环庚烷-6-基)乙酸叔丁酯
|
1268524-71-5
|
JQ-1 (carboxylic acid)
|
(6S)-4-(4-氯苯基)-2,3,9-三甲基-6H-噻吩并[3,2-F][1,2,4]噻唑并[4,3-A][1,4]二氮杂卓-6-乙酸
|
202592-23-2
|
Selisistat R-enantiomer
|
848193-69-1
|
848193-69-1
|
BAZ2-ICR
|
BAZ2-ICR
|
1665195-94-7
|
ORY-1001(trans)
|
1431303-72-8
|
1431303-72-8
|
MS023 dihydrochloride
|
MS023 二盐酸盐
|
1992047-64-9
|
p32 Inhibitor M36
|
P32 INHIBITOR M36 (M36)
|
802555-85-7
|
P300/CBP-IN-3
|
P300/CBP-IN-3
|
2299226-01-8
|
A-3 hydrochloride
|
赤霉酸
|
78957-85-4
|
N-Desmethyltamoxifen hydrochloride
|
N-去甲基三苯氧胺 盐酸盐
|
15917-65-4
|
INO-1001
|
INO-1001
|
501364-82-5
|
Guadecitabine sodium
|
929904-85-8
|
929904-85-8
|
SIRT-IN-3
|
2-(苯基氨基)苯甲酰胺
|
1211-19-4
|
GSK-J1
|
N-[2-(2-吡啶基)-6-(1,2,4,5-四氢-3H-3-苯并氮杂卓-3-基)-4-嘧啶基]-BETA-丙氨酸
|
1373422-53-7
|
BIX-01338 hydrate
|
1-{2-[4-(4-Methoxybenzoyloxy)phenyl]ethyl}-2-(4-trifluoromethylbenzoylamino)-1H-benzoimidazole-5-carboxylic acid hydrate
|
1228184-65-3
|
BAY-598
|
BAY-598(S-isomer)
|
1906919-67-2
|
DS-437
|
DS-437
|
1674364-87-4
|
O-Desmethyl Midostaurin
|
Benzamide, N-[(9S,10R,11R,13R)-2,3,10,11,12,13-hexahydro-10-hydroxy-9-methyl-1-oxo-9,13-epoxy-1H,9H-diindolo[1,2,3-gh:3',2',1'-lm]pyrrolo[3,4-j][1,7]benzodiazonin-11-yl]-N-methyl-
|
740816-86-8
|
PKC-iota inhibitor 1
|
2-氨基-5-(3-(哌嗪-1-基)苯基)-N-(吡啶-4-基)烟酰胺
|
2328094-11-5
|
SETD2-IN-1 TFA
|
EZM0414 TFA
|
2411759-92-5
|
YF-2 hydrochloride
|
YF-2 HYDROCHLORIDE
|
1312005-62-1
|
CARM1-IN-1 hydrochloride
|
CARM1-IN-1 (hydrochloride)
|
2070018-31-2
|
Bromodomain inhibitor-8
|
BROMODOMAIN INHIBITOR-8
|
1300031-70-2
|
PARP14 inhibitor H10
|
PARP14 INHIBITOR H10
|
2084811-68-5
|
GSK-3484862
|
GSK-3484862
|
2170136-65-7
|
SIRT7 inhibitor 97491
|
N1-(5-(4-氯苯基)恶唑-2-基)苯-1,3-二胺
|
1807758-81-1
|
ζ-Stat trisodium
|
8-羟基-1,3,6-萘三磺酸三钠盐
|
31894-34-5
|
Tenovin-1
|
TENOVIN-1
|
380315-80-0
|
Ingenol Mebutate
|
巨大戟醇-3-O-当归酸酯
|
75567-37-2
|
UNC 669
|
UNC669
|
1314241-44-5
|
BET-BAY 002
|
1588521-78-1
|
1588521-78-1
|
EPZ020411 hydrochloride
|
EPZ020411 HCL
|
2070015-25-5
|
MS402
|
MS-402
|
1672684-68-2
|
BJE6-106
|
BJE6-106
|
1564249-38-2
|
C-7280948
|
C7280948
|
587850-67-7
|
CBP/P300 bromodomain inhibitor-3
|
|
2304416-91-7
|